At a glance
ClinicalIndex Comparison RecordN/ACompleted· 14 enrolled
Drug / intervention
Psychotherapyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Narrative Therapy for Treatment-Resistant Obsessive-Compulsive Disorder
In Brief
A clinical study evaluating Psychotherapy for Obsessive-Compulsive Disorder. Completed, enrolled 14 participants across 1 site.
Detailed Summary
This is a prospective exploratory study using narrative therapy in group format, over 20 sessions, 2 hours per session, weekly, to determine whether this modality can provide any benefit to OCD symptoms, mood, sense of social connectedness, sense of identity, and/or quality of life in individuals living with treatment-resistant OCD. NOTE: an amendment is now in place so that the group can occur virtually given the COVID pandemic; Zoom will be used as our platform.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObsessive-Compulsive Disorder
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedNov 2019
Enrollment StartJan 2021
Primary CompletionAug 2021
Study CompletionSep 2021
TodayJul 2026
First PostedNov 6, 2019
Enrollment StartJan 2, 2021
Primary CompletionAug 1, 2021
Study CompletionSep 2, 2021
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 6.7 years ago
Interventions
Psychotherapyother
Group psychotherapy